Ori Spotlight

Deanna M. Petersen, Chief Business Officer at AVROBIO joins Jason C. Foster on the new episode of Ori Spotlight. 

Having led mergers and acquisitions for with some of the biggest names in biotech including Shire's $4.2 billion acquisition of ViroPharma, Deanna is unquestionably a powerhouse leader in the space. 

Now, as the 4th employee at AVROBIO, she talks about how she built a pipeline of personalized gene therapies and some of the challenges she faced. The biggest? Chemistry, Manufacturing and Controls (CMCs).

Learn more about Deanna M. Petersen | www.linkedin.com/in/dmpetersen

Learn more about Ori Biotech | www.oribiotech.com 

For episode three of Ori Spotlight, Bruce Levine, PhD., Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania Perelman School of Medicine and current President of International Society for Cell and Gene Therapy (ISCT) joins our host Jason C. Foster. 

Professor Levine pioneered the very first FDA approved CAR-T therapy Kymriah®and is a driving force across the cell and gene therapy industry, holding numerous positions at some of the most progressive CGT institutions in the world. 

In this episode he shares his perspectives on the industry shift that is needed to enable widespread access to these life-saving treatments and the responsibility of all stakeholders to make it happen.

Learn more about Ori Biotech: www.oribiotech.com | 

In this episode of Ori Spotlight, Jason C. Foster is joined by Tom and Emily Whitehead, along with Vincent Carrano, Director of Development and Engagement at the Emily Whitehead Foundation.

The Emily Whitehead Foundation is on a mission to make promising research and therapies, including CAR T-cell therapy, as well other immunotherapies more accessible to all patients.

Together we discuss Emily’s journey as the first child to take part in a T-cell trial, as well as the access challenges for patients in need of innovative cell and gene therapies.

Order The Whitehead Family's new book | ‘Praying for Emily’

Connect with Ori Biotech | www.oribiotech.com/connect 

Learn more about the Emily Whitehead Foundation | www.emilywhiteheadfoundation.org

On this week’s episode of Ori Spotlight, Jason C. Foster is joined by Anthony Davies, Founder and CEO of Dark Horse Consulting. 

Anthony has spent more than 20 years sharing his leadership experience in product, process and manufacturing development to cell and gene therapy (CGT) companies in need. 

We discuss some of the most significant barriers to innovation and scale in CGT and how they impact patients.

Learn more about Ori Biotech: www.oribiotech.com | [email protected]

Learn more about Dark Horse Consulting: https://darkhorseconsultinggroup.com